A two-day virtual conference for healthcare providers interested in bringing pharmacogenomics into practice.
Features live lectures from experts (with Q&A), moderated breakout discussions, and a virtual poster session. As an added benefit, registrants will have unlimited access to video recordings of the presentations after the conference.
Pharmacogenomics (PGx) is the science of how an individual’s genetic background affects response to medications—and the field has left the research realm to emerge as an important tool for clinical care. Many academic and large private health systems have implemented PGx, and now smaller non-academic centers are beginning or considering implementation into routine practice. Consumer interest in PGx testing is likewise growing, fueled by availability of direct-to-consumer tests.
Having a clear understanding of the current scientific evidence, emerging evidence, and knowledge of successful implementation pathways and examples are critical for your success in clinical pharmacogenomics.
Speakers and Agenda:
First 250 registrants before July 15 receive free genotyping. Continuing education credits will be offered.
▶ Drug-gene pairs commonly implemented in practice, and emerging data for new drug-gene pairs
▶ Efforts by CPIC in authoring guidelines
▶ A behind-the-scenes look at CPIC’s scientific review process
▶ Strategies for return of PGx results to patients
▶ Use of PGx information in the absence of guidelines
▶ The science behind implementation
▶ Best practices and strategies for implementing PGx
▶ Successful pathways to implementation at four distinct health systems
▶ Selecting a PGx testing laboratory, rules-building and clinical decision support for PGx, and more